MedPath

A prospective study for evaluation of efficacy of a 12mm diameter polytetrafluoroethylene partial covered stent in malignant extrahepatic biliary obstructio

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0005989
Lead Sponsor
Asan Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
161
Inclusion Criteria

1) Adult patients aged 19 to under 80 years of age
2) Patients who are closed to malignancy, which is not surgical or resectable
3) Patients with obstructive obstruction caused by lymph node metastasis in the primary carcinoma other than the liver
4) Patients who cannot or fail endoscopic stent implantation
5) Patients who have not previously undergone bile duct surgery
6) Patients with an expected survival rate of at least 2 months (Eastern Cooperative Oncology Group Performance Status [ECOG-PS] less than 3 points)

Exclusion Criteria

1) Patients who had previously undergone endoscopic stent implantation or bile duct surgery
2) Patients with expansion of biliary tract in the liver or external biliary tract in the liver
3) Hemophilia patients
4) Patients with three or more ECOG points

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Opening rate: Opening rate of 12mm diameter PTFE covered stent for treatment of malignant extrahepatic biliary obstruction.
Secondary Outcome Measures
NameTimeMethod
Analysis of complications related to treatment;Analysis of survival rate of patients
© Copyright 2025. All Rights Reserved by MedPath